Abstract:BACKGROUND:HeartModel (HM) is a fully automated adaptive quantification software that can quickly quantify left heart volume and left ventricular function. This study used HM to quantify the left ventricular end-diastolic (LVEDV) and end-systolic volumes (LVESV) of patients with dilated cardiomyopathy (DCM), coronary artery heart disease with segmental wall motion abnormality, and hypertrophic cardiomyopathy (HCM) to determine whether there were differences in the feasibility, accuracy, and repeatability of measuring the LVEDV, LVESV, LV ejection fraction (LVEF) and left atrial end-systolic volume (LAESV) and to compare these measurements with those obtained with traditional two-dimensional (2D) and three-dimensional (3D) methods.AIM:To evaluate the application value of HM in quantifying left heart chamber volume and LVEF in clinical patients.METHODS:A total of 150 subjects who underwent 2D and 3D echocardiography were divided into 4 groups: (1) 42 patients with normal heart shape and function (control group, Group A); (2) 35 patients with DCM (Group B); (3) 41 patients with LV remodeling after acute myocardial infarction (Group C); and (4) 32 patients with HCM (Group D). The LVEDV, LVESV, LVEF and LAESV obtained by HM with (HM-RE) and without regional endocardial border editing (HM-NE) were compared with those measured by traditional 2D/3D echocardiographic methods to assess the correlation, consistency, and repeatability of all methods.RESULTS:(1) The parameters measured by HM were significantly different among the groups (P < 0.05 for all). Compared with Groups A, C, and D, Group B had higher LVEDV and LVESV (P < 0.05 for all) and lower LVEF (P < 0.05 for all); (2) HM-NE overestimated LVEDV, LVESV, and LAESV with wide biases and underestimated LVEF with a small bias; contour adjustment reduced the biases and limits of agreement (bias: LVEDV, 28.17 mL, LVESV, 14.92 mL, LAESV, 8.18 mL, LVEF, -0.04%). The correlations between HM-RE and advanced cardiac 3D quantification (3DQA) (r s = 0.91-0.95, P < 0.05 for all) were higher than those between HM-NE (r s = 0.85-0.93, P < 0.05 for all) and the traditional 2D methods. The correlations between HM-RE and 3DQA were good for Groups A, B, and C but remained weak for Group D (LVEDV and LVESV, r s = 0.48-0.54, P < 0.05 for all); and (3) The intraobserver and interobserver variability for the HM-RE measurements were low.CONCLUSION:HM can be used to quantify the LV volume and LVEF in patients with common heart diseases and sufficient image quality. HM with contour editing is highly reproducible and accurate and may be recommended for clinical practice.

Experimental Study on Assessment of Left and Right Ventricular Mass by Real-Time Three-Dimensional Echocardiography

OP12.05: Full‐volume Three‐dimensional Echocardiographic Assessment of Right Ventricular Volume in Normal Fetuses

Full-volume Real-Time Three-Dimensional Echocardiographic Assessment on Right Ventricular Function of Fetuses in the Second and Third Trimester

Three-dimensional Echocardiographic Assessment of Left Ventricular Volume in Different Heart Diseases Using a Fully Automated Quantification Software.

Two-Dimensional Tissue Tracking: A Novel Echocardiographic Technique To Measure Left Atrial Volume: Comparison With Biplane Area Length Method And Real Time Three-Dimensional Echocardiography

Quantitative study of right ventricular function in the normal second and third trimester fetuses by M-mode tricuspid annular displacement

The Correlation Study of Left Ventricular Systolic Function Calculated by Automated Cardiac Motion Quantification

Assessment of Real-Time Three-Dimensional Echocardiography As a Tool for Evaluating Left Atrial Volume and Function in Patients with Type 2 Diabetes Mellitus.

Real-time three-dimensional echocardiography in assessment of right ventricular volume and systolic function:an animal study

Full-volume Three-Dimensional Echocardiographic Assessment of Left Ventricular Volume in Healthy Human Fetuses

Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass in adult patients whose EF≥45%

In Vitro Validation of Right Ventricular Volume and Mass Measurement by Real‐Time Three‐Dimensional Echocardiography

Evaluation of Left Ventricular Segmental Function in Patients with Coronary Disease Before and after Percutaneous Coronary Intervention by Real-Time Three-Dimentional Echocardiography

Comparison of real-time three-dimensional transthoracic echocardiograpby with magnetic resonance imaging for assessment of left ventricular mass in elderly patients

A Comparative Study of Three-Dimensional Real-Time Echocardiography and MRI in the Assessment of Right Ventricular Cardiac Function

Comparison of Real-Time Three-Dimensional Echocardiography to Magnetic Resonance Imaging for Assessment of the Left Ventricle Volumes in Patients Whose Left Ventricle Ejection Fraction More Than 45%

Evaluation of right ventricular regional volume and systolic function in normal adults using real-time three-dimensional echocardiography

Quantitative Assessment of Right Ventricle by Dynamic Three Dimensional Voxel Imaging of Echocardiography

Assessment of Left Ventricle Volume Filling Curve with Magnetic Resonance Imaging: a Preliminary Study

Accuracy and reproducibility of real-time three-dimensional echocardiography for assessment of right ventricular volumes and ejection fraction in children.

Role of Real-Time Three Dimensional Echocardiography in the Assessment of Right Ventricular Function of Repaired Tetralogy of Fallot